Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.

Ramirez AG, Weiss NS, Holden AE, Suarez L, Cooper SP, Munoz E, Naylor SL.

PLoS One. 2012;7(4):e35573. doi: 10.1371/journal.pone.0035573. Epub 2012 Apr 18.

2.

Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasion.

Sudarshan S, Shanmugasundaram K, Naylor SL, Lin S, Livi CB, O'Neill CF, Parekh DJ, Yeh IT, Sun LZ, Block K.

PLoS One. 2011;6(6):e21037. doi: 10.1371/journal.pone.0021037. Epub 2011 Jun 14.

3.

Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.

Beuten J, Garcia D, Brand TC, He X, Balic I, Canby-Hagino E, Troyer DA, Baillargeon J, Hernandez J, Thompson IM, Leach RJ, Naylor SL.

J Urol. 2009 Oct;182(4):1614-20. doi: 10.1016/j.juro.2009.06.016. Epub 2009 Aug 15.

PMID:
19683737
4.

A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.

Park JS, Sharma LK, Li H, Xiang R, Holstein D, Wu J, Lechleiter J, Naylor SL, Deng JJ, Lu J, Bai Y.

Hum Mol Genet. 2009 May 1;18(9):1578-89. doi: 10.1093/hmg/ddp069. Epub 2009 Feb 10.

5.

Association of polymorphisms in TGFB1 and prostate cancer prognosis.

Brand TC, Bermejo C, Canby-Hagino E, Troyer DA, Baillargeon J, Thompson IM, Leach RJ, Naylor SL.

J Urol. 2008 Feb;179(2):754-8. Epub 2007 Dec 20.

PMID:
18082198
6.

SNPs associated with prostate cancer risk and prognosis.

Naylor SL.

Front Biosci. 2007 May 1;12:4111-31. Review.

PMID:
17485362
7.

PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors.

Deshpande AM, Akunowicz JD, Reveles XT, Patel BB, Saria EA, Gorlick RG, Naylor SL, Leach RJ, Hansen MF.

Oncogene. 2007 Mar 15;26(12):1714-22. Epub 2006 Sep 25.

8.

The DNA sequence, annotation and analysis of human chromosome 3.

Muzny DM, Scherer SE, Kaul R, Wang J, Yu J, Sudbrak R, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Wei S, Wheeler DA, Wright MW, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clendenning J, Clerc-Blankenburg KP, Chen R, Chen Z, Davis C, Delgado O, Dinh HH, Dong W, Draper H, Ernst S, Fu G, Gonzalez-Garay ML, Garcia DK, Gillett W, Gu J, Hao B, Haugen E, Havlak P, He X, Hennig S, Hu S, Huang W, Jackson LR, Jacob LS, Kelly SH, Kube M, Levy R, Li Z, Liu B, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Palmeiri A, Pasternak S, Perez LM, Phelps KA, Plopper FJ, Qiang B, Raymond C, Rodriguez R, Saenphimmachak C, Santibanez J, Shen H, Shen Y, Subramanian S, Tabor PE, Verduzco D, Waldron L, Wang J, Wang J, Wang Q, Williams GA, Wong GK, Yao Z, Zhang J, Zhang X, Zhao G, Zhou J, Zhou Y, Nelson D, Lehrach H, Reinhardt R, Naylor SL, Yang H, Olson M, Weinstock G, Gibbs RA.

Nature. 2006 Apr 27;440(7088):1194-8.

PMID:
16641997
9.

Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.

Vijayakumar S, Hall DC, Reveles XT, Troyer DA, Thompson IM, Garcia D, Xiang R, Leach RJ, Johnson-Pais TL, Naylor SL.

Cancer Res. 2006 Apr 15;66(8):4055-64.

10.

The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice.

Vijayakumar S, Garcia D, Hensel CH, Banerjee M, Bracht T, Xiang R, Kagan J, Naylor SL.

Genes Chromosomes Cancer. 2005 Dec;44(4):365-72.

PMID:
16080199
11.

Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis.

Troyer DA, Mubiru J, Leach RJ, Naylor SL.

Dis Markers. 2004;20(2):117-28. Review.

12.

A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).

Dearnaley DP, Sydes MR, Mason MD, Stott M, Powell CS, Robinson AC, Thompson PM, Moffat LE, Naylor SL, Parmar MK; Mrc Pr05 Collaborators.

J Natl Cancer Inst. 2003 Sep 3;95(17):1300-11.

PMID:
12953084
13.

Prostate cancer and prostate-specific antigen: the more we know, the less we understand.

Thompson I, Leach RJ, Pollock BH, Naylor SL.

J Natl Cancer Inst. 2003 Jul 16;95(14):1027-8. No abstract available.

PMID:
12865440
14.

Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice.

Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL.

Cancer Res. 2002 May 1;62(9):2637-43.

15.
16.

Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP.

Science. 2001 Aug 3;293(5531):864-7.

17.

Initial sequencing and analysis of the human genome.

Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann Y, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blöcker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowki J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, Szustakowki J; International Human Genome Sequencing Consortium.

Nature. 2001 Feb 15;409(6822):860-921. Erratum in: Nature 2001 Aug 2;412(6846):565. Nature 2001 Jun 7;411(6838):720. Szustakowki, J [corrected to Szustakowski, J].

18.

Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3.

Hejna JA, Timmers CD, Reifsteck C, Bruun DA, Lucas LW, Jakobs PM, Toth-Fejel S, Unsworth N, Clemens SL, Garcia DK, Naylor SL, Thayer MJ, Olson SB, Grompe M, Moses RE.

Am J Hum Genet. 2000 May;66(5):1540-51. Epub 2000 Apr 12.

19.

Identification of a putative regulatory subunit of a calcium-activated potassium channel in the dup(3q) syndrome region and a related sequence on 22q11.2.

Riazi MA, Brinkman-Mills P, Johnson A, Naylor SL, Minoshima S, Shimizu N, Baldini A, McDermid HE.

Genomics. 1999 Nov 15;62(1):90-4.

PMID:
10585773
20.

An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers.

Timmer T, Terpstra P, van den Berg A, Veldhuis PM, Ter Elst A, van der Veen AY, Kok K, Naylor SL, Buys CH.

Genomics. 1999 Sep 1;60(2):238-40.

PMID:
10486216
21.

A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.

Timmer T, Terpstra P, van den Berg A, Veldhuis PM, Ter Elst A, Voutsinas G, Hulsbeek MM, Draaijers TG, Looman MW, Kok K, Naylor SL, Buys CH.

Eur J Hum Genet. 1999 May-Jun;7(4):478-86.

22.

A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A.

Rabert DK, Koch BD, Ilnicka M, Obernolte RA, Naylor SL, Herman RC, Eglen RM, Hunter JC, Sangameswaran L.

Pain. 1998 Nov;78(2):107-14.

PMID:
9839820
23.

Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.

Lott ST, Lovell M, Naylor SL, Killary AM.

Cancer Res. 1998 Aug 15;58(16):3533-7.

24.
25.

Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients.

Maassen VanDenBrink A, Vergouwe MN, Ophoff RA, Naylor SL, Dauwerse HG, Saxena PR, Ferrari MD, Frants RR.

Am J Med Genet. 1998 Jun 5;77(5):415-20.

PMID:
9632173
26.

Genetic structure and chromosomal mapping of MyD88.

Hardiman G, Jenkins NA, Copeland NG, Gilbert DJ, Garcia DK, Naylor SL, Kastelein RA, Bazan JF.

Genomics. 1997 Oct 15;45(2):332-9.

PMID:
9344657
27.

Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.

van den Berg A, Draaijers TG, Kok K, Timmer T, Van der Veen AY, Veldhuis PM, de Leij L, Gerhartz CD, Naylor SL, Smith DI, Buys CH.

Genes Chromosomes Cancer. 1997 Aug;19(4):220-7.

PMID:
9258656
28.

Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with a missense mutation in the COL7A1 gene.

Winberg JO, Hammami-Hauasli N, Nilssen O, Anton-Lamprecht I, Naylor SL, Kerbacher K, Zimmermann M, Krajci P, Gedde-Dahl T Jr, Bruckner-Tuderman L.

Hum Mol Genet. 1997 Jul;6(7):1125-35.

PMID:
9215684
29.

Assignment of the human peroxisomal branched-chain acyl-CoA oxidase gene to chromosome 3p21.1-p14.2 by rodent/human somatic cell hybridization.

Moghrabi NN, Naylor SL, Van Veldhoven PP, Baumgart E, Dawson DB, Bennett MJ.

Biochem Biophys Res Commun. 1997 Feb 24;231(3):767-9.

PMID:
9070889
30.

Assignment of SAFB encoding Hsp27 ERE-TATA binding protein (HET)/scaffold attachment factor B (SAF-B) to human chromosome 19 band p13.

DuPont BR, Garcia DK, Sullivan TM, Naylor SL, Oesterreich S.

Cytogenet Cell Genet. 1997;79(3-4):284-5. No abstract available.

PMID:
9605873
31.

Assignment of the gene for human tetranectin (TNA) to chromosome 3p22-->p21.3 by somatic cell hybrid mapping.

Durkin ME, Naylor SL, Albrechtsen R, Wewer UM.

Cytogenet Cell Genet. 1997;76(1-2):39-40.

PMID:
9154122
32.

Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.

Kok K, Naylor SL, Buys CH.

Adv Cancer Res. 1997;71:27-92. Review.

PMID:
9111863
33.

Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis.

Kruzelock RP, Murphy EC, Strong LC, Naylor SL, Hansen MF.

Cancer Res. 1997 Jan 1;57(1):106-9.

34.

An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo.

Todd MC, Xiang RH, Garcia DK, Kerbacher KE, Moore SL, Hensel CH, Liu P, Siciliano MJ, Kok K, van den Berg A, Veldhuis P, Buys CH, Killary AM, Naylor SL.

Oncogene. 1996 Dec 5;13(11):2387-96.

PMID:
8957080
35.

Linkage and cytogenetic mapping of a CAG repeat containing human cDNA to 3p24.2-p22.

Polymeropoulos MH, Ide SE, Becker K, Naylor SL.

Cancer Genet Cytogenet. 1996 Nov;92(1):46-9.

PMID:
8956871
36.

Structural characterization and fine chromosomal mapping of the human P2Y1 purinergic receptor gene (P2RY1).

Ayyanathan K, Naylor SL, Kunapuli SP.

Somat Cell Mol Genet. 1996 Sep;22(5):419-24.

PMID:
9039850
37.

Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer.

Xiang RH, Hensel CH, Garcia DK, Carlson HC, Kok K, Daly MC, Kerbacher K, van den Berg A, Veldhuis P, Buys CH, Naylor SL.

Genomics. 1996 Feb 15;32(1):39-48.

PMID:
8786119
38.

Report of the Third International Workshop on Human Chromosome 8 Mapping. San Antonio, Texas, October 25-27, 1996.

Leach RJ, Banga SS, Ben-Othame K, Chughtai S, Clarke R, Daiger SP, Kolehmainen J, Kumar S, Kuo M, Macoska J, Mada N, Naylor SL, Nunes M, O'Connell P, Pebusque MJ, Pekkel V, Porter CJ, Simons CT, Sohocki MM, Trapman J, Wells D, Westbrook C, Wood S.

Cytogenet Cell Genet. 1996;75(2-3):71-84. No abstract available.

PMID:
9040775
39.

Report of the sixth international workshop on human chromosome 3 mapping 1995.

Naylor SL, Carritt B, Boileau C, Beroud C, Alexander C, Allderdice P, Alimov A, Ashworth T, Bonifas J, Bugert P, Buys CH, Chipperfield MA, Deng G, Drabkin H, Gemmill RM, Grompe M, Joensuu T, Jonasdottir A, Gizatullin R, Krols L, Leach RJ, Lott ST, Killary A, Martinsson T, Messiaen L, et al.

Cytogenet Cell Genet. 1996;72(4):255-70. No abstract available.

PMID:
8641130
40.

Mapping 638 STSs to regions of human chromosome 3.

Naylor SL, Moore S, Garcia D, Xiang X, Xin X, Mohrer M, Reus B, Linn R, Stanton V, O'Connell P, Leach RJ.

Cytogenet Cell Genet. 1996;72(1):90-4.

PMID:
8565645
41.

Report and abstracts of the fifth international workshop on human chromosome 3 mapping 1994. Ann Arbor, Michigan, May 8-9, 1994.

Smith DI, Glover TW, Gemmill R, Drabkin H, O'Connell P, Naylor SL.

Cytogenet Cell Genet. 1995;68(3-4):125-46. No abstract available.

PMID:
7842730
42.

Characterization of the mouse loricrin gene: linkage with profilaggrin and the flaky tail and soft coat mutant loci on chromosome 3.

Rothnagel JA, Longley MA, Bundman DS, Naylor SL, Lalley PA, Jenkins NA, Gilbert DJ, Copeland NG, Roop DR.

Genomics. 1994 Sep 15;23(2):450-6.

PMID:
7835895
43.

Two novel human serine/threonine kinases with homologies to the cell cycle regulating Xenopus MO15, and NIMA kinases: cloning and characterization of their expression pattern.

Levedakou EN, He M, Baptist EW, Craven RJ, Cance WG, Welcsh PL, Simmons A, Naylor SL, Leach RJ, Lewis TB, et al.

Oncogene. 1994 Jul;9(7):1977-88.

PMID:
8208544
44.

Assignment of xeroderma pigmentosum group C (XPC) gene to chromosome 3p25.

Legerski RJ, Liu P, Li L, Peterson CA, Zhao Y, Leach RJ, Naylor SL, Siciliano MJ.

Genomics. 1994 May 1;21(1):266-9.

PMID:
8088800
45.

Dinucleotide repeat polymorphism (D3S1776) on human chromosome 3p.

Todd S, Naylor SL, Drabkin HA, Gemmill RM.

Hum Mol Genet. 1994 May;3(5):841. No abstract available.

PMID:
8081381
46.

Report and abstracts of the Fourth International Workshop on Human Chromosome 3 Mapping.

Naylor SL, Buys CH, Carritt B.

Cytogenet Cell Genet. 1994;65(1-2):2-50. No abstract available.

PMID:
8104766
47.

A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.

Daly MC, Xiang RH, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD, Naylor SL.

Oncogene. 1993 Jul;8(7):1721-9.

PMID:
8390035
48.
49.

Characterization of NIGMS human/rodent somatic cell hybrid mapping panel 2 by PCR.

Dubois BL, Naylor SL.

Genomics. 1993 May;16(2):315-9.

PMID:
8314569
50.

Dinucleotide repeat polymorphisms at the D2S108 and D2S109 loci.

Todd S, Naylor SL.

Hum Mol Genet. 1993 Apr;2(4):490. No abstract available.

PMID:
8504316

Supplemental Content

Loading ...
Support Center